Comparison of Monoclonal Antibody Cocktail (Casirivimab-Imdevimab) Treatment With Remdesivir and Favipiravir in Mild to Moderate COVID-19 Infection: A Retrospective Study

Comparison of Monoclonal Antibody Cocktail (Casirivimab-Imdevimab) Treatment With Remdesivir and Favipiravir in Mild to Moderate COVID-19 Infection: A Retrospective Study

Introduction: Favipiravir and remdesivir are antiviral drugs being used in the present pandemic and were also used previously for other viral infections in the past. Monoclonal antibody (Mab) Casirivimab-Imdevimab is a Coronavirus Disease 2019 neutralising antibody approved in the last one year. The...

Full description

Bibliographic Details
Main Authors: Rahul Rajaram Tambe, Anupa Resham Ashok Hinduja, Harshad Limaye, Ashwini Jogade, Aishwarya Pillai, Astha Trivedi
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2023-02-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
antiviral
recovered
vaccination
Online Access:https://jcdr.net/articles/PDF/17402/57428_CE(AD)_F(IS)_PF1(JY_OM)_PFA(SS)_PB(JY_SS)_PFA1(SS)_PN(SS).pdf

Similar Items

Similar Items